Nothing Special   »   [go: up one dir, main page]

Levi-Montalcini, 1965 - Google Patents

Tissue and Nerve Growth Promoting Factors: Biological Aspects of Specific Growth Promoting Factors

Levi-Montalcini, 1965

View PDF
Document ID
9981765358890747073
Author
Levi-Montalcini R
Publication year
Publication venue
Proceedings of the Royal Society of Medicine

External Links

Snippet

The recognition of the growth promoting activity elicited by a variety of agents belonging to the class of hormones as well as to the less well defined category of'growth factors' dates back to the second half of the past century. However, only much more recently have the …
Continue reading at journals.sagepub.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants

Similar Documents

Publication Publication Date Title
Takigawa et al. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2)
Ramachandran et al. Inhibition of replication of normal adrenocortical cells in culture by adrenocorticotropin.
Pelton et al. Differential expression of genes encoding TGFs β1, β2, and β3 during murine palate formation
Mayer et al. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons—i. Effectsin vitro
Houck et al. Functional failures of cultured human diploid fibroblasts after continued population doublings
Angeletti et al. The nerve growth factor (NGF): chemical properties and metabolic effects
Fitzgerald et al. Rapid restitution of the rat pancreas following acinar cell necrosis subsequent to ethionine
Acquaviva et al. Cell-free synthesis of rat insulin-like growth factor II
Hatanaka et al. Septal cholinergic neurons from postnatal rat can survive in the dissociate culture conditions in the presence of nerve growth factor
Levi-Montalcini Tissue and Nerve Growth Promoting Factors: Biological Aspects of Specific Growth Promoting Factors
Wagshal et al. Regulatory substances produced by lymphocytes. VI. Cell cycle specificity of inhibitor of DNA synthesis action in L cells.
Kent et al. Changes in serum proteins during growth of malignant cells in vitro.
Kawada et al. Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP
Jimenez et al. Tumor cell rejection through terminal cell differentiation
Maurizi et al. Morphological and functional characteristics of human temporal-bone cell cultures
Kent et al. Selective uptake of serum globulins and glycoproteins by cells growing in vitro
Levi-Montalcini Reprinted from Proceedings of the Royal Society of Medicine, May 1965, Vol. 58, No. 5, pp. 357-360 (Section of Experimental Medicine and Therapeutics, pp. 1–4).
KR890002411B1 (en) Producing method for adult t-cell leukemia associated cell line
CN104726400A (en) Animal-source-free component culture method for differentiation from human pluripotent stem cells to germ cells
Wessells Thyroxine initiation of epidermal differentiation as studied in vitro in chemically defined medium
US7776818B2 (en) Methods to treat T-cell disorders using TISF
Rendall et al. Cyclic 3′ 5′ adenosine monophosphate inhibition of sulfation factor activity
van der Bosch et al. Growth state-specific responsiveness of primary cultures of a nude mouse-xenografted human colon carcinoma to 4′-deoxydoxorubicin and a crude human leukocyte α-interferon preparation
JPH05508769A (en) β-Aretin useful for cell culture and therapy
Cravioto et al. Metachromatic leukodystrophy (sulfatide lipidoses) cultured in vitro